
Entornos Controlados
GMP Annex 1 · AEMPS · EMA · FDA · Full DQ/IQ/OQ/PQ
GMP environments with the complete Contamination Control Strategy required by the revised Annex 1.
En detalle
Building a pharmaceutical cleanroom is necessary. Passing a regulatory inspection is the real objective. Our GMP environments deliver the complete Contamination Control Strategy (CCS) required by the revised Annex 1 (EU, 2022): pressure cascades, segregated personnel and material flows, validated gowning-room architecture, certifiable surface finishes. ICH Q7 for active substances. ICH Q9 for quality risk management. GMP Annex 15 for qualification and validation. DQ/IQ/OQ/PQ as a standard deliverable.
Regulatory framework covered: Regulation (EU) 2023/1182 and GMP Annex 1, EMA guidelines, FDA 21 CFR Parts 210 and 211. For Spanish-speaking markets: AEMPS (Spain), COFEPRIS (Mexico), ANMAT (Argentina), and INVIMA (Colombia) — all with expedited pathways that recognize EMA and FDA as reference authorizations. One documentation package. Every market.
Preservation environments for museums and archives, with stable temperature and humidity plus continuous monitoring.